ABBV
NYSEStockAbbVie Inc.
$226.53-1.05 (-0.46%)
52-Week Range
$170.16
$244.38
Key Stats
Market Cap
400.6B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.33
Volume
3.9M
Avg Volume
6.5M
Performance
1M
+2.36%
3M
+1.95%
6M
+4.63%
YTD
-0.71%
1Y
+7.37%
3Y
+49.84%
5Y
+106.49%
Price Chart
ETF Exposure
ABBV is held by 454 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MEDX | Horizon Kinetics Medical ETF | 8.60% |
| MEDI | Harbor Health Care ETF (MEDI) | 7.55% |
| XLV | State Street Health Care Select Sector SPDR ETF | 7.24% |
| JDOC | JPMorgan Healthcare Leaders ETF | 7.11% |
| IYH | iShares U.S. Healthcare ETF | 7.01% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 6.40% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 6.34% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 6.21% |
| VHT | Vanguard Health Care ETF | 6.00% |
| WBIY | WBI Power Factor High Dividend ETF | 5.61% |
| HDV | iShares Core High Dividend ETF | 5.60% |
| TERM | EquityCompass Tactical Risk Manager ETF | 5.57% |
| RXL | ProShares - Ultra Health Care | 5.38% |
| PJP | Invesco Pharmaceuticals ETF | 5.21% |
| USCF | Themes US Cash Flow Champions ETF | 5.15% |
| IXJ | iShares Global Healthcare ETF | 5.09% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 5.04% |
| LGCF | Themes US Cash Flow Champions ETF | 5.00% |
| HDIV | QRAFT AI-Enhanced U.S. High Dividend ETF | 4.99% |
| FLAG | Global X - S&P 500 U.S. Market Leaders Top 50 ETF | 4.64% |
| PINK | Simplify Health Care ETF | 4.59% |
| DHS | WisdomTree U.S. High Dividend Fund | 4.56% |
| PPH | VanEck Pharmaceutical ETF | 4.23% |
| WBIL | WBI BullBear Quality 3000 ETF | 4.18% |
| RND | First Trust Bloomberg R&D Leaders ETF | 4.17% |
| UDI | USCF ESG Dividend Income Fund | 4.15% |
| PSIL | AdvisorShares Psychedelics ETF | 4.09% |
| SIXH | ETC 6 Meridian Hedged Equity Index Option ETF | 3.83% |
| GBDV | Global Beta Smart Income ETF | 3.56% |
| SCHD | Schwab U.S. Dividend Equity ETF | 3.56% |
| ERNZ | TRUESHARES ACTIVE YIELD ETF | 3.45% |
| RSMV | Relative Strength Managed Volatility Strategy ETF | 3.45% |
| USMC | Principal U.S. Mega-Cap ETF | 3.38% |
| LNGR | Global X Aging Population ETF | 3.20% |
| DIVL | Madison Dividend Value ETF | 3.16% |
| DIVS | SmartETFs Dividend Builder ETF | 3.07% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 3.01% |
| XOEX | Xtrackers S&P 100 Ex Top 20 ETF | 3.00% |
| AGNG | Global X - Aging Population ETF | 2.94% |
| QDF | FlexShares Quality Dividend Index Fund | 2.93% |
| QDEF | FlexShares Quality Dividend Defensive Index Fund | 2.93% |
| ABFL | Abacus FCF Leaders ETF | 2.89% |
| COWS | Amplify Cash Flow Dividend Leaders ETF | 2.86% |
| ABOT | Abacus FCF Innovation Leaders ETF | 2.71% |
| DGRO | iShares Core Dividend Growth ETF | 2.64% |
| HCOW | Amplify COWS Covered Call ETF | 2.60% |
| DSTL | Distillate U.S. Fundamental Stability & Value ETF | 2.54% |
| STXD | Strive 1000 Dividend Growth ETF | 2.50% |
| CANC | Tema Oncology ETF | 2.40% |
| AVIE | Avantis Inflation Focused Equity ETF | 2.39% |
Page 1 of 10Next
About ABBV ETF Exposure
AbbVie Inc. (ABBV) is held by 454 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 400.6B, ABBV is a widely held institutional stock. The stock currently trades at $226.53. Investors can gain exposure to ABBV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABBV, sorted by portfolio weight.